Cooperative Research Centre for Biomedical Imaging Development Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2010
NCT01620749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

18f fpm (1 trial)

18f mel050 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Squamous Cell (Phase 1)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2